Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors

被引：0
|
作者：
Z. Kondera-Anasz
A. Mielczarek-Palacz
J. Sikora
机构：
[1] Medical University of Silesia,Department of Immunology and Serology
来源：
Apoptosis | 2005年 / 10卷
关键词：
sFas; sFasL; uterine tumors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
It is commonly accepted that apoptosis plays an important role in the death of normal and neoplastic cells. Related proteins and their receptors on cell surfaces regulate apoptosis. One of the best-characterized systems is the Fas-Fas ligand system. The aim of the study was to examine the concentrations of soluble Fas receptor (sFas) and the soluble ligand for the Fas receptor (sFasL) in serum of women with uterine tumors.
引用
收藏
页码：1143 / 1149
页数：6
相关论文
共 50 条
  • [31] Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure
    Nakae, H
    Narita, K
    Endo, S
    JOURNAL OF CRITICAL CARE, 2001, 16 (02) : 59 - 63
  • [32] Soluble Fas and Fas Ligand in Pregnancy: Influence of Hypertension
    Karthikeyan, Velore J.
    Lip, Gregory Y. H.
    Baghdadi, Sabah
    Lane, Deirdre A.
    Beevers, D. Gareth
    Blann, Andrew D.
    ANGIOLOGY, 2012, 63 (01) : 35 - 38
  • [33] Clinical significance of serum soluble Fas, Fas ligand and Fas in intrahepatic lymphocytes in chronic hepatitis C
    El Sayed Zaki, Maysaa
    Auf, Fatma Abbas
    El Ghawalby, Nabieh Anwar
    El Saddal, Nirmeen Mohamed
    IMMUNOLOGICAL INVESTIGATIONS, 2008, 37 (02) : 163 - 170
  • [34] The factors responsible for serum levels of soluble Fas-ligand and Fas-receptor after myocardial infarction
    Iakovleva, A. S.
    Mirolyubova, O. A.
    CARDIOVASCULAR RESEARCH, 2012, 93 : S42 - S42
  • [35] Significance of Fas/Fas ligand and soluble Fas/Fas ligand system in patients with bile duct carcinoma
    Murakami, M
    Sasaki, T
    Tsuchida, A
    Kawasaki, Y
    Morinaka, K
    Fujimoto, Y
    Kariya, K
    Kuwada, Y
    Yamasaki, S
    Kuwahara, K
    Miyata, H
    Tyayama, K
    GASTROENTEROLOGY, 2002, 122 (04) : A442 - A442
  • [36] Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
    Vincent, Fabien B.
    Kandane-Rathnayake, Rangi
    Koelmeyer, Rachel
    Harris, James
    Hoi, Alberta Y.
    Mackay, Fabienne
    Morand, Eric F.
    LUPUS SCIENCE & MEDICINE, 2020, 7 (01):
  • [37] Highly sensitive ELISA for soluble fas in serum: Increased soluble Fas in the elderly
    Seishima, M
    Takemura, M
    Saito, K
    Sano, H
    Minatoguchi, S
    Fujiwara, H
    Hachiya, T
    Noma, A
    CLINICAL CHEMISTRY, 1996, 42 (12) : 1911 - 1914
  • [38] Significance of serum soluble Fas ligand in patients with bladder carcinoma
    Mizutani, Y
    Hongo, F
    Sato, N
    Ogawa, O
    Yoshida, O
    Miki, T
    CANCER, 2001, 92 (02) : 287 - 293
  • [39] Serum levels of soluble Fas ligand in patients with acute and fulminant hepatitis:: relationship with soluble Fas, tumor necrosis factor α and TNF receptor-1
    Suzuki, K
    Endo, R
    Nakamura, N
    Yatomi, T
    Iwai, M
    Abe, K
    Takikawa, Y
    Sato, S
    HEPATOLOGY RESEARCH, 2000, 17 (01) : 19 - 30
  • [40] Serum soluble fas ligand levels in familial Mediterranean fever
    Ceri, Mevlut
    Unverdi, Selman
    Senes, Mehmet
    Altay, Mustafa
    Yilmaz, Rahmi
    Yucel, Dogan
    Duranay, Murat
    RENAL FAILURE, 2013, 35 (06) : 835 - 837
12345